Washington is turning a blind eye as consumers and small businesses pay the price for harmful and corrupt practices.
Today, California launched a new agency that will promote economic growth and protect the public from abuses. https://t.co/e3ikVtGUaM
@rogbennett - 2011. Become MiB fan. Live across Polk St from Bob’s. I ask the guy what they do with all the leftover donuts. “We use them for our bread pudding.” So as a gotcha I ask what they do with all their leftover bread pudding. “We never have any leftover bread pudding.”🎯
MMMM. DONUTS. Traveling to the Bay Area for soccer this summer? Stop by local San Francisco staple Bob’s Donuts and take on the donut challenge if you dare.
For more small businesses like this, check out the Men in Blazers City Guides presented by @Visa: https://t.co/RXe0wjtJQw
Should the federal government force insurers and PBMs to divest medical service providers in order to prevent the rise of health care prices and spending? This JAMA Viewpoint shares my thoughts on this policy idea. https://t.co/lnsI7B5CQG @Kennedy_School@HarvardHBS @HBSHealth
I was desperately homesick and @2fiftybbq (original location, not k street) plus a hearty hello from @Fernando_GoPe healed me.
They are on @BBQsnob’s best bbq outside of Texas list for a reason…
🚨CMS has announced that the BALANCE model for GLP-1 obesity coverage will not launch in Medicare in 2027 and the Bridge demo will run through 2027 (it was set to run from July-Dec '26). This could add billions in Medicare spending in 2026/27 since the gov't is footing the bill.
@ZacharyBrennan@SarahKarlin I think it’s the first five firms to sign - all from September - November. May just not have had enough time to make the launch date.
Headline you don’t usually see on Fox News:
“Trump’s ‘new’ healthcare idea is a painful prescription for working Americans”
- Biden appointee @JessicaSchubel
Spotted this morning — a second CMMI model that continues Trump administration’s push on Most Favored Nation drug-price cuts.
I’m told that GLOBE is a mandatory Part B model and GUARD is a mandatory Part D model.
Both come as White House seeks to pressure, cajole pharma.
Happy Pythagorean Triple Square Day!
Today’s date is made of 3 perfect squares and they form a Pythagorean triple: 3² + 4² = 5²
This only happens once a century.
Long time lurker, breaking a decade of silence to share an essay on what I've learned from scientists about making medicines (spoiler: it's hard) and why the future looks bright (also spoiler: AI) 🧵
Given the new Executive Order on drug prices, my just published article in the Journal of Economic Perspectives may be of interest.
We shouldn’t fool ourselves that there won’t be trade offs from a policy such as this. In the article, I summarize and discuss what we know.
In ordinary times, this would get attention.
CBO projects the Medicare Part A Trust Fund will be depleted in 2052, versus 2035 in last year's report.
Also important, but still TBD, is the outlook for Medicare Part B spending, which affects premiums.
https://t.co/eEShxipMnN
The advent of generic liraglutide (an older GLP-1 drug) could help Medicare negotiate a lower price for Ozempic and Wegovy — via @john_wilkerson
https://t.co/9oOrxQThiT
The paper answers 2 important questions:
1. What information is presented in provider directories?
2. What information do consumer actually want to see?
We surveyed EVERY ACA marketplace directory in EVERY state & fielded a national survey to find out
What will happen to drug pricing reform post-election? Talked with @ZoeyBecker13 on Fierce Pharma's "The Top Line" podcast about VP Harris's plans, how Pres. Trump helped pass the IRA, and how to read Project 2025.
TY Zoey/@AylaEllison for having me on.
https://t.co/1frRHU4pSQ
RFK is positioning for control of public health agencies, perhaps as a White House czar. He's raising questions about vaccines. And he's got a list of who he wants in government with him.
@LaurenWeberHP@jdawsey1@michaelscherer@rachel_roubein + me.
https://t.co/cmYL9bqKyX